When examining the YFP+ tumor cells from LDHi- versus vehicle control–treated tumors, we observed a decrease in ex vivo tumor glucose uptake based on glucose-Cy3 staining as well as a decrease in GLUT1 and LDH expression by flow cytometry (Figure 4B). Here, SLC2A1 is linked to neoplasm.